Median duration of response and time to progression
Population . | No. . | Duration of response, mos. (range) . | Time to progression, mos. (range) . |
|---|---|---|---|
| All patients | 51 | 11.7 (0.7-74.3+) | 9.3 (0.9-75.5+) |
| Responders | 37 | 11.7 (0.7-74.3+) | 12.6 (1.8-75.5+) |
| CR/CRu patients | 26 | 12.4 (0.7-74.3+) | 13.4 (1.8-75.5+) |
| CR/CRu patients (0.4 mCi/kg [14.8 MBq/kg]) | 13 | 27.5 (0.7-74.3+) | 28.3 (1.8-75.5+) |
| CR patients (0.4 mCi/kg [14.8 MBq/L]) | 8 | 44.0 (6.4-74.3+) | 45.0 (7.5-75.5+) |
| All DLCL patients | 12 | 49.8 (1.3-67.6+) | 4.6 (0.9-68.6+) |
Population . | No. . | Duration of response, mos. (range) . | Time to progression, mos. (range) . |
|---|---|---|---|
| All patients | 51 | 11.7 (0.7-74.3+) | 9.3 (0.9-75.5+) |
| Responders | 37 | 11.7 (0.7-74.3+) | 12.6 (1.8-75.5+) |
| CR/CRu patients | 26 | 12.4 (0.7-74.3+) | 13.4 (1.8-75.5+) |
| CR/CRu patients (0.4 mCi/kg [14.8 MBq/kg]) | 13 | 27.5 (0.7-74.3+) | 28.3 (1.8-75.5+) |
| CR patients (0.4 mCi/kg [14.8 MBq/L]) | 8 | 44.0 (6.4-74.3+) | 45.0 (7.5-75.5+) |
| All DLCL patients | 12 | 49.8 (1.3-67.6+) | 4.6 (0.9-68.6+) |